Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MedMira Inc MMIRF


Primary Symbol: V.MIR

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

Recent & Breaking News (TSXV:MIR)

MedMira Opens US Subsidiary in Atlanta, GA

Canada NewsWire July 20, 2015

MedMira Reports Third Quarter Results

Canada NewsWire May 29, 2015

MedMira Submits Reveal G4 Whole Blood Rapid HIV Test For U.S. FDA Approval

Canada NewsWire April 20, 2015

MedMira Directors Granted Stock Options

Canada NewsWire April 13, 2015

MedMira Closes Equity Investment with OnSite Lab

Canada NewsWire March 27, 2015

MedMira Expands U.S. Growth Plan with New Equity Investment from OnSite Lab

Canada NewsWire March 25, 2015

MedMira Reports Second Quarter Results

Canada NewsWire March 20, 2015

MedMira Board of Directors Re-elected at Annual Shareholders Meeting

Canada NewsWire February 5, 2015

Two of MedMira's Multiplo(TM) Tests Procured for UNAIDS Program in Central Asia

Canada NewsWire January 28, 2015

MedMira Reports First Quarter Results

Canada NewsWire December 24, 2014

MedMira Reports 2014 Fourth Quarter and Year End Financial Results

Canada NewsWire November 28, 2014

MedMira Names Robyn Cook as Chief Corporate Officer

Canada NewsWire November 4, 2014

MedMira Scores New Contract to Develop Rapid Colon Cancer Test with Beacon Biomedical

Canada NewsWire October 8, 2014

MedMira Closes New Equity Investment to Expand Sales & Marketing in Key Markets

Canada NewsWire October 2, 2014

MedMira Expands Multiplo Product Range with Three New Rapid Vertical Flow Tests

Canada NewsWire July 16, 2014

MedMira (V.MIR) ramps up Chinese market share with additional tender sales

Stockhouse Editorial July 14, 2014

Top Ranking MedMira Rapid HIV Test Garners Additional Tender Sales in China

Canada NewsWire July 14, 2014

MedMira Announces Chief Financial Officer Transition

Canada NewsWire July 11, 2014

MedMira Reports Third Quarter Results

Canada NewsWire June 27, 2014

MedMira Showcases its Multiplo Line of Rapid Tests at the 2014 STD Prevention Conference

Canada NewsWire June 10, 2014